# Orbital rhabdomyosarcoma in an adult: a misleading presentation

**Authors:** Mohamed Bouallou, Issam Berrajaa, Achraf Amine Sbai, Mohammed El Magroud, Drissia Benfadil, Amal Bennani, Azeddine Lachkar

PMC · DOI: 10.1016/j.radcr.2026.01.101 · 2026-02-28

## TL;DR

A rare case of adult orbital rhabdomyosarcoma presented with misleading nasal symptoms, but was successfully treated with chemotherapy and radiotherapy.

## Contribution

This case highlights the diagnostic challenges and successful treatment of a rare adult rhabdomyosarcoma with sinonasal extension.

## Key findings

- The patient showed excellent clinical and radiologic response to VAC chemotherapy and radiotherapy.
- Advanced imaging and histopathology were crucial for accurate diagnosis and management.
- The case underscores the rarity and unusual presentation of adult orbital rhabdomyosarcoma.

## Abstract

Rhabdomyosarcoma is the most common malignant mesenchymal tumor in children, whereas its occurrence in adults is exceptionally rare. When it occurs in this population, initial presentation with nonspecific rhinologic symptoms is unusual and may delay recognition of the underlying malignancy. We report the case of a 29-year-old woman who presented with progressive right-sided nasal obstruction and hyposmia, subsequently complicated by the rapid onset of unilateral proptosis. Cross-sectional imaging revealed a poorly circumscribed ethmoido-orbito-nasal mass with skull base erosion and orbital invasion, exhibiting aggressive radiologic features that initially raised suspicion for esthesioneuroblastoma. Histopathological examination ultimately confirmed alveolar rhabdomyosarcoma, staged as T2BN1M0 (IRS Group III). The patient underwent multimodal treatment combining VAC chemotherapy and conformal radiotherapy (45 Gy), resulting in an excellent clinical and radiologic response, with complete resolution of proptosis and significant visual recovery at 1-year follow-up. This case emphasizes the diagnostic challenges of adult orbital rhabdomyosarcoma with sinonasal extension and highlights the pivotal role of advanced imaging and histopathology in guiding accurate diagnosis and appropriate management. The rarity and unusual clinical presentation of this case underscore its value for publication.

## Linked entities

- **Diseases:** rhabdomyosarcoma (MONDO:0005212), esthesioneuroblastoma (MONDO:0016029), proptosis (MONDO:0004770)

## Full-text entities

- **Genes:** CD99 (CD99 molecule (Xg blood group)) [NCBI Gene 4267] {aka HBA71, MIC2, MIC2X, MIC2Y, MSK5X}, ADA2 (adenosine deaminase 2) [NCBI Gene 51816] {aka ADGF, CECR1, IDGFL, PAN, SNEDS, VAIHS}, PTPRC (protein tyrosine phosphatase receptor type C) [NCBI Gene 5788] {aka B220, CD45, CD45R, GP180, IMD105, L-CA}, DES (desmin) [NCBI Gene 1674] {aka CDCD3, CSM1, CSM2, LGMD1D, LGMD1E, LGMD2R}, PAX3 (paired box 3) [NCBI Gene 5077] {aka CDHS, HUP2, PAX-3, WS1, WS3}, FOXO1 (forkhead box O1) [NCBI Gene 2308] {aka FKH1, FKHR, FOXO1A}, MYOG (myogenin) [NCBI Gene 4656] {aka MYF4, bHLHc3, myf-4}, SYP (synaptophysin) [NCBI Gene 6855] {aka MRX96, MRXSYP, XLID96}
- **Diseases:** Orbital rhabdomyosarcoma (MESH:C537605), lymphadenopathy (MESH:D008206), Rhabdomyosarcoma (MESH:D012208), epistaxis (MESH:D004844), Esthesioneuroblastoma (MESH:D018304), mesenchymal tumor (MESH:C535700), proptosis (MESH:D005094), facial pain (MESH:D005157), orbital cellulitis (MESH:D054517), Sinonasal squamous cell carcinoma (MESH:D002294), alveolar RMS (MESH:D002282), cervical lymphadenopathy (MESH:D002575), systemic disease (MESH:D034721), inflammation (MESH:D007249), nodal disease (MESH:D004194), small cell carcinoma (MESH:D018288), visual loss (MESH:D014786), adult alveolar RMS (MESH:C538052), small round blue-cell tumors (MESH:D058405), sinusitis (MESH:D012852), calcifications (MESH:D002114), benign (MESH:D009369), edema (MESH:D004487), Lymphoma (MESH:D008223), mucosal (MESH:D052016), lymph node metastases (MESH:D008207), Adult orbital and sinonasal masses (MESH:D009916), pleomorphic RMS (MESH:D008228), allergic rhinosinusitis (MESH:D000092562), purulent rhinorrhea (MESH:D003234), nasal obstruction (MESH:D015508), grade III (MESH:D001254), eyelid (MESH:D005141), alveolar rhabdomyosarcoma (MESH:D018232), diplopia (MESH:D004172), III (MESH:C537189), sinonasal and orbital tumors (MESH:D009918), inferior turbinate hypertrophy (MESH:D006984), embryonal RMS (MESH:D018236), toxicity (MESH:D064420), sinonasal alveolar RMS (MESH:C535701), bone destruction (MESH:D001847), nodal (MESH:D013611), Ewing sarcoma (MESH:D012512), hyposmia (MESH:D000086582), ptosis (MESH:C564553)
- **Chemicals:** vincristine (MESH:D014750), ifosfamide (MESH:D007069), gadolinium (MESH:D005682), VAC (-), actinomycin D (MESH:D003609), doxorubicin (MESH:D004317)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Figures

6 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12966728/full.md

---
Source: https://tomesphere.com/paper/PMC12966728